Archived:Clear cell renal cell carcinoma: Difference between revisions
| [unchecked revision] | [unchecked revision] |
| Line 55: | Line 55: | ||
=== From Cosmic Mutated in >20% === | === From Cosmic Mutated in >20% === | ||
[[VHL]] (43%), [[PBRM1]] (30%) | |||
=== Mutated in 10-20% === | === Mutated in 10-20% === | ||
=== Mutated in 5-10% === | |||
[[BAP1]] (11%), [[SETD2]] (11%) | |||
=== Mutated in 5-10% === | |||
[[KDMC5]] (6%), [[TP53]] (5%) | |||
=== Mutated in 2-5% === | === Mutated in 2-5% === | ||
=== mtDNA === | |||
[[PTEN]], [[KMT2C]], [[AKAP9]], [[KMT2D]], [[TERT]], [[RANBP2]], [[PIK3CA]], [[ATM]], [[ARID1A]], [[CDKN2A]], [[SRGAP3]], [[SMARCA4]], [[MLLT4]], [[TCF12]] | |||
=== mtDNA === | |||
== Epigenomics (methylation) == | == Epigenomics (methylation) == | ||